PARATEK PHARMACEUTICALS

Lobbying for PARATEK PHARMACEUTICALS · Pharmaceuticals - Antibiotics & Biodefense

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Mar 27, 2026

Expenses

$20,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 5

Defense, Dept of (DOD)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Budget/Appropriations

FY 27 DOD Appropriations FY 27 HHS Appropriations Biodefense Funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.